TransCode Therapeutics, Inc. Common Stock (NASDAQ: RNAZ) last traded at $1.63, down 12.37% on the session. The quote above updates while this page is open; the figures below are drawn from TransCode Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
TransCode Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker RNAZ. Its market capitalisation is $27.60 million.
Valuation measures for TransCode Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $27.60M |
|---|---|
| Enterprise value | $31.87M |
| Beta | 0.93 |
Trailing-twelve-month figures tagged in TransCode Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$42.83M |
|---|---|
| Cash |
|---|
| $8.38M |
Range and volume for RNAZ over the past 52 weeks.
| 52-week high | $15.90 |
|---|---|
| 52-week low | $1.52 |
| Volume | 31.6K |
| Average volume | 51.1K |
| Previous close | $1.86 |
Invest a chosen dollar amount in TransCode Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RNAZ.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.